Where Change Control. identifies a need for additional supporting stability data on validation batches, ALLERGAN will consult with GSK on any additional programme and testing protocols.
Appears in 2 contracts
Sources: Supply Agreement (Allergan Inc), Supply Agreement (Allergan Inc)